Molecular analysis of PROS1 in subjects with free protein S level below 1st percentile, as determined in MEGA controls
Subject number* . | Venous thrombosis . | fPS (U/dL) . | tPS (U/dL) . | Sequence change† . | Predicted protein change‡ . | Reference . | Comments . |
---|---|---|---|---|---|---|---|
1 | No | 16 | 123 | — | — | — | |
2 | Yes | 18 | 63 | 967delTinsGG | Phe323fs | NOVEL | |
3 | Yes | 18 | 68 | — | — | — | — |
4 | Yes | 22 | 64 | (?_-133)_(1_?*)del | Complete deletion | 5,10,11 | — |
5 | Yes | 30 | 74 | — | — | — | — |
6 | Yes | 30 | 58 | 431C>A | Thr144Asn | 40 | Associated with quantitative deficiency of protein S |
7 | No | 31 | 54 | — | — | — | — |
8 | No | 32 | 50 | — | — | — | — |
9 | Yes | 33 | 78 | — | — | — | — |
10 | Yes | 33 | 88 | — | — | — | — |
11 | No | 34 | 63 | ||||
12 | No | 34 | 90 | 370G>A* | — | — | 3′UTR. NOVEL |
13 | No | 34 | 66 | — | — | — | — |
14 | Yes | 34 | 53 | — | — | — | — |
15 | No | 34 | 99 | — | — | — | — |
16 | Yes | 36 | 63 | — | — | — | — |
17 | Yes | 37 | 66 | 684C>G | Cys228Trp | — | NOVEL |
18 | No | 37 | 57 | — | — | — | — |
19 | Yes | 38 | 60 | — | — | — | — |
20 | No | 39 | 96 | — | — | — | — |
21 | Yes | 39 | 81 | — | — | — | — |
22 | No | 39 | 65 | — | — | — | — |
23 | Yes | 40 | 70 | — | — | — | — |
24 | Yes | 40 | 58 | — | — | — | — |
25 | No | 40 | 74 | 1301T>C | Val434Ala | rs6803112 | |
25 | No | 40 | 74 | 1501T>G | Ser501Ala | 23 | Protein S Heerlen |
26 | Yes | 40 | 76 | — | — | — | — |
27 | No | 40 | 81 | — | — | — | — |
28 | No | 40 | 57 | — | — | — | — |
29 | No | 41 | 76 | — | — | — | — |
30 | Yes | 41 | 61 | — | — | — | — |
31 | Yes | 41 | 53 | — | — | — | — |
32 | No | 41 | 81 | 1501T>G | Ser501Ala | 23 | Protein S Heerlen |
33 | No | 41 | 82 | — | — | — | — |
34 | Yes | 42 | 69 | — | — | — | — |
35 | Yes | 42 | 81 | — | — | — | — |
36 | No | 42 | 59 | — | — | — | — |
37 | Yes | 42 | 43 | — | — | — | — |
38 | No | 42 | 96 | — | — | — | — |
39 | Yes | 43 | 74 | — | — | — | — |
40 | Yes | 43 | 77 | — | — | — | — |
41 | No | 43 | 62 | — | — | — | — |
42 | No | 43 | 132 | — | — | — | — |
43 | No | 43 | 60 | 698G>A | Arg233Lys | 7,41,42 | rs41267007 |
Probably neutral polymorphism | |||||||
44 | Yes | 43 | 60 | 814G>A | Gly272Arg | — | rs41267005 |
45 | No | 44 | 61 | 1095T>G | Asn365Lys | — | NOVEL |
46 | No | 44 | 63 | — | — | — | — |
47 | No | 45 | 88 | — | — | — | — |
48 | Yes | 45 | 77 | — | — | — | — |
Subject number* . | Venous thrombosis . | fPS (U/dL) . | tPS (U/dL) . | Sequence change† . | Predicted protein change‡ . | Reference . | Comments . |
---|---|---|---|---|---|---|---|
1 | No | 16 | 123 | — | — | — | |
2 | Yes | 18 | 63 | 967delTinsGG | Phe323fs | NOVEL | |
3 | Yes | 18 | 68 | — | — | — | — |
4 | Yes | 22 | 64 | (?_-133)_(1_?*)del | Complete deletion | 5,10,11 | — |
5 | Yes | 30 | 74 | — | — | — | — |
6 | Yes | 30 | 58 | 431C>A | Thr144Asn | 40 | Associated with quantitative deficiency of protein S |
7 | No | 31 | 54 | — | — | — | — |
8 | No | 32 | 50 | — | — | — | — |
9 | Yes | 33 | 78 | — | — | — | — |
10 | Yes | 33 | 88 | — | — | — | — |
11 | No | 34 | 63 | ||||
12 | No | 34 | 90 | 370G>A* | — | — | 3′UTR. NOVEL |
13 | No | 34 | 66 | — | — | — | — |
14 | Yes | 34 | 53 | — | — | — | — |
15 | No | 34 | 99 | — | — | — | — |
16 | Yes | 36 | 63 | — | — | — | — |
17 | Yes | 37 | 66 | 684C>G | Cys228Trp | — | NOVEL |
18 | No | 37 | 57 | — | — | — | — |
19 | Yes | 38 | 60 | — | — | — | — |
20 | No | 39 | 96 | — | — | — | — |
21 | Yes | 39 | 81 | — | — | — | — |
22 | No | 39 | 65 | — | — | — | — |
23 | Yes | 40 | 70 | — | — | — | — |
24 | Yes | 40 | 58 | — | — | — | — |
25 | No | 40 | 74 | 1301T>C | Val434Ala | rs6803112 | |
25 | No | 40 | 74 | 1501T>G | Ser501Ala | 23 | Protein S Heerlen |
26 | Yes | 40 | 76 | — | — | — | — |
27 | No | 40 | 81 | — | — | — | — |
28 | No | 40 | 57 | — | — | — | — |
29 | No | 41 | 76 | — | — | — | — |
30 | Yes | 41 | 61 | — | — | — | — |
31 | Yes | 41 | 53 | — | — | — | — |
32 | No | 41 | 81 | 1501T>G | Ser501Ala | 23 | Protein S Heerlen |
33 | No | 41 | 82 | — | — | — | — |
34 | Yes | 42 | 69 | — | — | — | — |
35 | Yes | 42 | 81 | — | — | — | — |
36 | No | 42 | 59 | — | — | — | — |
37 | Yes | 42 | 43 | — | — | — | — |
38 | No | 42 | 96 | — | — | — | — |
39 | Yes | 43 | 74 | — | — | — | — |
40 | Yes | 43 | 77 | — | — | — | — |
41 | No | 43 | 62 | — | — | — | — |
42 | No | 43 | 132 | — | — | — | — |
43 | No | 43 | 60 | 698G>A | Arg233Lys | 7,41,42 | rs41267007 |
Probably neutral polymorphism | |||||||
44 | Yes | 43 | 60 | 814G>A | Gly272Arg | — | rs41267005 |
45 | No | 44 | 61 | 1095T>G | Asn365Lys | — | NOVEL |
46 | No | 44 | 63 | — | — | — | — |
47 | No | 45 | 88 | — | — | — | — |
48 | Yes | 45 | 77 | — | — | — | — |
Mutations are described accordingly to the Human Genome Variation Society.43
– indicates individuals in whom no mutation was found.
fPS, free protein S; tPS, total protein S; MAF, minor allele frequency.
Numbers are accordingly to increasing levels of free protein S.
PROS1 coding DNA reference sequence is NM_000313.3.
Protein reference sequence is NP_000304.2.